Advancing
Toward a Cure

Lupus Therapeutics was established to advance lupus clinical research by finding more effective and safer treatments for people living with lupus. 

Advancing
Toward a Cure

Lupus Therapeutics was established to advance lupus clinical research by finding more effective and safer treatments for people living with lupus. 

Advanced turnkey operations
Lupus Therapeutics is the ONLY organization that:

   Offers a full suite of services, including study start-up services
   Leverages KOL and patient expertise
   Accesses the resources of the Lupus Research Alliance

Lupus Therapeutics offers a full suite of trial services – including study start-up and consultative services – throughout the clinical trial process. Only Lupus Therapeutics can leverage the network it oversees of 57 leading academic institutions and their thought-leading lupus expert researchers throughout North America. Lupus Therapeutics is a research innovation accelerator and affiliate organization of the Lupus Research Alliance, the world’s leading private funder of lupus research whose mission is to improve treatments while advancing toward a cure. Lupus Therapeutics has a track record of successfully collaborating on clinical studies with more than a dozen top global pharmaceutical companies committed to the lupus community.

Advanced turnkey operations
Lupus Therapeutics is the ONLY organization that:

  • Offers a full suite of services, including study start-up services
  • Leverages KOL and patient expertise
  • Accesses the resources of the Lupus Research Alliance

Lupus Therapeutics offers a full suite of trial services – including study start-up and consultative services – throughout the clinical trial process. Only Lupus Therapeutics can leverage the network it oversees of 57 leading academic institutions and their thought-leading lupus expert researchers throughout North America. Lupus Therapeutics is a research innovation accelerator and affiliate organization of the Lupus Research Alliance, the world’s leading private funder of lupus research whose mission is to improve treatments while advancing toward a cure. Lupus Therapeutics has a track record of successfully collaborating on clinical studies with more than a dozen top global pharmaceutical companies committed to the lupus community.

Accelerated lupus trials

Lupus Therapeutics is the ONLY organization that can shave months off the clinical research process, which means potentially delivering life-saving treatments sooner to people with lupus and their healthcare providers.

Our turnkey resources result in earlier trial fielding and faster patient enrollment. Earlier enrollment leads to earlier trial completion. Lupus Therapeutics’ established ecosystem of relationships – with academic centers, thought-leading lupus researchers, patient peer advocates and even IRBs – translates into short-cutting bureaucracy and start-up time. Our full continuum of services to expedite and streamline the research process results in faster, more efficient study time, which means earliest access to care, treatment and aspirationally a cure.

Accelerated lupus trials

Lupus Therapeutics is the ONLY organization that can shave months off the clinical research process, which means potentially delivering life-saving treatments sooner to people with lupus and their healthcare providers.

Our turnkey resources result in earlier trial fielding and faster patient enrollment. Earlier enrollment leads to earlier trial completion. Lupus Therapeutics’ established ecosystem of relationships – with academic centers, thought-leading lupus researchers, patient peer advocates and even IRBs – translates into short-cutting bureaucracy and start-up time. Our full continuum of services to expedite and streamline the research process results in faster, more efficient study time, which means earliest access to care, treatment and aspirationally a cure.

Affiliated academic network

Lupus Therapeutics is the ONLY clinical research organization that is a conduit to and collaborates with leading academic institutions and researchers/thought leaders/experts in lupus.

While clinical research organizations (CROs) generally reach out to community-based hospitals for access to their patient populations, Lupus Therapeutics has created and oversees the Lupus Clinical Investigators Network (LuCIN), a lupus clinical trials network composed of many of the most reputable academic medical research centers in the world.

Affiliated academic network

Lupus Therapeutics is the ONLY clinical research organization that is a conduit to and collaborates with leading academic institutions and researchers/thought leaders/experts in lupus.

While clinical research organizations (CROs) generally reach out to community-based hospitals for access to their patient populations, Lupus Therapeutics has created and oversees the Lupus Clinical Investigators Network (LuCIN), a lupus clinical trials network composed of many of the most reputable academic medical research centers in the world.

Acceleration in action case study

Eli Lilly, a world leader in immunology, engaged the full suite of Lupus Therapeutics services to help prioritize its pipeline and quickly advance candidates into human trials. 

View the case study